$QS
QuantumScape Corp

2020 Q3 Form 10-Q Financial Statement

#000156459020054203 Filed on November 16, 2020

View on sec.gov

Income Statement

Concept 2020 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.540M
YoY Change
% of Gross Profit
Research & Development $16.98M
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $20.69M
YoY Change
Operating Profit -$20.69M
YoY Change
Interest Expense $8.947M
YoY Change
% of Operating Profit
Other Income/Expense, Net -$355.2M
YoY Change
Pretax Income -$1.460M
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$375.9M
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share -$1.57
Diluted Earnings Per Share -$1.57
COMMON SHARES
Basic Shares Outstanding 239.9M
Diluted Shares Outstanding 239.9M

Balance Sheet

Concept 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.000M
YoY Change
Cash & Equivalents $10.57M
Short-Term Investments
Other Short-Term Assets $300.0K
YoY Change
Inventory
Prepaid Expenses $285.1K
Receivables
Other Receivables
Total Short-Term Assets $1.300M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $230.1M
YoY Change
Total Long-Term Assets $230.1M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.300M
Total Long-Term Assets $230.1M
Total Assets $231.4M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.24K
YoY Change
Accrued Expenses $1.156M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $100.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.337M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $8.100M
YoY Change
Total Long-Term Liabilities $8.100M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.337M
Total Long-Term Liabilities $8.100M
Total Liabilities $9.387M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$1.525M
YoY Change
Common Stock $6.525M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$247.0M
YoY Change
Total Liabilities & Shareholders Equity $231.4M
YoY Change

Cashflow Statement

Concept 2020 Q3
OPERATING ACTIVITIES
Net Income -$375.9M
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$680.0K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -60.00K
YoY Change
NET CHANGE
Cash From Operating Activities -680.0K
Cash From Investing Activities 0.000
Cash From Financing Activities -60.00K
Net Change In Cash -740.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$680.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
kcac Non Cash Deferred Underwriting Commissions In Connection With Initial Public Offering
NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering
8050000
CY2020Q3 kcac Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001811414
CY2020Q3 kcac Investments Held In Trust Account
InvestmentsHeldInTrustAccount
230075599
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1430502
CY2020Q3 kcac Administrative Expenses Related Party
AdministrativeExpensesRelatedParty
60000
kcac Administrative Expenses Related Party
AdministrativeExpensesRelatedParty
80000
CY2020Q3 us-gaap Franchisor Costs
FranchisorCosts
50000
us-gaap Franchisor Costs
FranchisorCosts
90548
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1538223
us-gaap Operating Income Loss
OperatingIncomeLoss
1601085
CY2020Q3 kcac Net Gain From Investments Held In Trust Account
NetGainFromInvestmentsHeldInTrustAccount
75599
kcac Net Gain From Investments Held In Trust Account
NetGainFromInvestmentsHeldInTrustAccount
75599
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1462589
us-gaap Net Income Loss
NetIncomeLoss
-1525451
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7053922
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6248452
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
0
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
13097867
CY2020Q2 kcac Value Of Shares Subject To Possible Redemption
ValueOfSharesSubjectToPossibleRedemption
218439270
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-62862
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5000001
CY2020Q3 kcac Value Of Shares Subject To Possible Redemption
ValueOfSharesSubjectToPossibleRedemption
-1462590
us-gaap Profit Loss
ProfitLoss
1525451
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
285083
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15238
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1070999
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
90548
CY2020Q3 us-gaap Cash
Cash
1002785
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1336785
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5000002
CY2020Q3 kcac Deferred Underwriting Commissions Non Current
DeferredUnderwritingCommissionsNonCurrent
8050000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-39345
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-0796578
dei Entity Address Address Line1
EntityAddressAddressLine1
1400 Old Country Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 301
dei Entity Address City Or Town
EntityAddressCityOrTown
Westbury
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11590
dei City Area Code
CityAreaCode
703
dei Local Phone Number
LocalPhoneNumber
674-6514
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
285083
CY2020Q3 us-gaap Assets
Assets
231363467
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
15238
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1155999
CY2020Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
90548
CY2020Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
75000
CY2020Q3 us-gaap Liabilities
Liabilities
9386785
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
216976680
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6524748
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1525451
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
231363467
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1428188
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-709348
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
230000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-230000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
75000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
230000000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6575000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4962867
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
231712133
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1002785
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1002785
us-gaap Stock Issued1
StockIssued1
216976680
kcac Non Cash Offering Costs Included In Accrued Expenses
NonCashOfferingCostsIncludedInAccruedExpenses
85000
CY2020Q3 kcac Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2020Q3 kcac Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2020Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q3 kcac Fair Value Liabilities Level1 To Level3 Transfers Amount
FairValueLiabilitiesLevel1ToLevel3TransfersAmount
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000<font style="color:#000000;">, and investments held in Trust Account</font>. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.<font style="color:#000000;"> The Company&#8217;s investments held in the Trust Account as of September 30, 2020 is comprised of </font>investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. treasury securities<font style="color:#000000;"> money market funds.</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
CY2020Q2 kcac Maximum Net Tangible Assets For Business Combination
MaximumNetTangibleAssetsForBusinessCombination
5000001
CY2020Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2020Q2 kcac Percentage Of Public Shares To Be Redeemed
PercentageOfPublicSharesToBeRedeemed
1.00
CY2020Q2 kcac Interest To Pay Dissolution Expenses
InterestToPayDissolutionExpenses
100000
CY2020Q3 kcac Business Combination Exchange Ratio
BusinessCombinationExchangeRatio
4.0032186234
CY2020Q3 kcac Proceeds From Sale Of Founders Shares
ProceedsFromSaleOfFoundersShares
25000
CY2020Q3 kcac Working Capital
WorkingCapital
42000
CY2020Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
kcac Cash Withdraw From Trust Account
CashWithdrawFromTrustAccount
0
CY2020Q3 kcac Concentrations Of Credit Risk Federal Depository Insurance Coverage Limit
ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit
250000
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-24183
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1438406
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1525451
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7053922
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6248452
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
kcac Description Of Public Warrant
DescriptionOfPublicWarrant
Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant.
kcac Period To Issue Warrant After Completion Of Initial Business Combination
PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination
P30D
CY2020Q3 kcac Underwriting Discount Per Unit
UnderwritingDiscountPerUnit
0.20
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
4600000
CY2020Q3 kcac Deferred Underwriting Commission Per Unit
DeferredUnderwritingCommissionPerUnit
0.35
CY2020Q3 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
The Class B common stock will automatically convert into Class A common stock at the time of the initial Business Combination, or earlier at the option of the holders, on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as described herein.
CY2020Q3 kcac Public Warrants Expiration Term
PublicWarrantsExpirationTerm
P5Y
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2020Q3 kcac Minimum Share Price Required For Redemption Of Warrants
MinimumSharePriceRequiredForRedemptionOfWarrants
18.00
CY2020Q3 kcac Percentage Of Proceeds From Share Issuances
PercentageOfProceedsFromShareIssuances
0.60
CY2020Q3 kcac Exercise Price Adjustment Percentage
ExercisePriceAdjustmentPercentage
1.15
CY2020Q3 kcac Redemption Trigger Price Adjustment Percentage
RedemptionTriggerPriceAdjustmentPercentage
1.80
CY2020Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q3 kcac Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2020Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0

Files In Submission

Name View Source Status
0001564590-20-054203-index-headers.html Edgar Link pending
0001564590-20-054203-index.html Edgar Link pending
0001564590-20-054203.txt Edgar Link pending
0001564590-20-054203-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kcac-10q_20200930.htm Edgar Link pending
kcac-20200930.xml Edgar Link completed
kcac-20200930.xsd Edgar Link pending
kcac-20200930_cal.xml Edgar Link unprocessable
kcac-20200930_def.xml Edgar Link unprocessable
kcac-20200930_lab.xml Edgar Link unprocessable
kcac-20200930_pre.xml Edgar Link unprocessable
kcac-ex311_8.htm Edgar Link pending
kcac-ex312_9.htm Edgar Link pending
kcac-ex321_6.htm Edgar Link pending
kcac-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending